US Stock MarketDetailed Quotes

SION Sionna Therapeutics

Watchlist
  • 12.050
  • +0.010+0.08%
Trading Apr 30 14:31 ET
531.70MMarket Cap-8.62P/E (TTM)

Sionna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.18%70.56M
43.97%18.13M
21.66%50.33M
12.6M
41.37M
Selling and administrative expenses
36.68%13.27M
43.44%3.88M
43.45%9.71M
--2.71M
--6.77M
-General and administrative expense
36.68%13.27M
43.44%3.88M
43.45%9.71M
--2.71M
--6.77M
Research and development costs
41.01%57.29M
44.12%14.25M
17.40%40.63M
--9.89M
--34.61M
Operating profit
-40.18%-70.56M
-43.97%-18.13M
-21.66%-50.33M
-12.6M
-41.37M
Net non-operating interest income expense
195.05%8.17M
283.18%2.12M
144.61%2.77M
553K
1.13M
Non-operating interest income
195.05%8.17M
283.18%2.12M
144.61%2.77M
--553K
--1.13M
Other net income (expense)
131.89%698K
0.00%166K
301K
166K
Other non- operating income (expenses)
131.89%698K
0.00%166K
--301K
--166K
----
Income before tax
-30.52%-61.69M
-33.45%-15.85M
-17.45%-47.26M
-11.88M
-40.24M
Income tax
Net income
-30.52%-61.69M
-33.45%-15.85M
-17.45%-47.26M
-11.88M
-40.24M
Net income continuous Operations
-30.52%-61.69M
-33.45%-15.85M
-17.45%-47.26M
---11.88M
---40.24M
Minority interest income
Net income attributable to the parent company
-30.52%-61.69M
-33.45%-15.85M
-17.45%-47.26M
-11.88M
-40.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.52%-61.69M
-33.45%-15.85M
-17.45%-47.26M
-11.88M
-40.24M
Basic earnings per share
14.52%-1.4534
12.61%-0.3734
26.76%-1.7003
-0.4272
-2.3217
Diluted earnings per share
14.52%-1.4534
12.61%-0.3734
26.76%-1.7003
-0.4272
-2.3217
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(FY)Dec 31, 2022
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.18%70.56M43.97%18.13M21.66%50.33M12.6M41.37M
Selling and administrative expenses 36.68%13.27M43.44%3.88M43.45%9.71M--2.71M--6.77M
-General and administrative expense 36.68%13.27M43.44%3.88M43.45%9.71M--2.71M--6.77M
Research and development costs 41.01%57.29M44.12%14.25M17.40%40.63M--9.89M--34.61M
Operating profit -40.18%-70.56M-43.97%-18.13M-21.66%-50.33M-12.6M-41.37M
Net non-operating interest income expense 195.05%8.17M283.18%2.12M144.61%2.77M553K1.13M
Non-operating interest income 195.05%8.17M283.18%2.12M144.61%2.77M--553K--1.13M
Other net income (expense) 131.89%698K0.00%166K301K166K
Other non- operating income (expenses) 131.89%698K0.00%166K--301K--166K----
Income before tax -30.52%-61.69M-33.45%-15.85M-17.45%-47.26M-11.88M-40.24M
Income tax
Net income -30.52%-61.69M-33.45%-15.85M-17.45%-47.26M-11.88M-40.24M
Net income continuous Operations -30.52%-61.69M-33.45%-15.85M-17.45%-47.26M---11.88M---40.24M
Minority interest income
Net income attributable to the parent company -30.52%-61.69M-33.45%-15.85M-17.45%-47.26M-11.88M-40.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -30.52%-61.69M-33.45%-15.85M-17.45%-47.26M-11.88M-40.24M
Basic earnings per share 14.52%-1.453412.61%-0.373426.76%-1.7003-0.4272-2.3217
Diluted earnings per share 14.52%-1.453412.61%-0.373426.76%-1.7003-0.4272-2.3217
Dividend per share
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Constellation Brands
STZ
187.290
eBay
EBAY
67.490
Lantheus
LNTH
104.246
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.115
5
Halozyme Therapeutics
HALO
60.880
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.